The CSC niche, characterized by hypoxia, has been reported to undergo a metabolic switch to a more invasive program [5], and to promote tumor neovascularization by producing high levels of proangiogenic factors such as vascular endothelial growth factor (VEGF), and interleukin 8 (IL-8). The gene discussed is VEGFA; the disease is neoplasm.